Researchers reviewed and summarized the safety and efficacy of individual antispasmodics available in North America for the treatment of chronic abdominal pain.
All articles by Vincent Soreca
Practitioners working in Tamil Nadu, India, once a COVID-19 hotspot, shared their experience with managing gastrointestinal services at the peak of the pandemic.
Researchers analyzed data from patients with chronic non-cancer pain and opioid-induced constipation to determine PAC-SYM and PAC-QOL minimal clinically important difference values.
Investigators aimed to discern any gastrointestinal adverse drug reactions associated with remdesivir in patients with COVID-19.
Researchers sought to assess the association of IBD medications and their combinations on the risk of severe COVID-19 outcomes.
Investigators conducted a study to assess the effects of COVID-19 on pediatric gastroenterology practice in an effort to develop strategies to prepare for a future resurgence and/or pandemic.